Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,268
Closed -$224K 469
2023
Q1
$224K Sell
7,268
-1,940
-21% -$73.9K 0.02% 383
2022
Q4
$346K Buy
9,208
+258
+3% +$10.2K 0.03% 280
2022
Q3
$336K Sell
8,950
-245
-3% -$9.72K 0.03% 275
2022
Q2
$331K Sell
9,195
-250
-3% -$10.3K 0.03% 291
2022
Q1
$463K Buy
9,445
+4,645
+97% +$235K 0.03% 259
2021
Q4
$230K Buy
+4,800
New +$227K 0.02% 314

Other funds holding SNV

American Trust's SNV Position: Q2 2023 in Review

American Trust sold out of Synovus (SNV) in Q2 2023, closing a stake of 7,268 shares — an estimated $224K sold.

American Trust first reported a position in SNV in Q4 2021 and held it in 6 quarters. The position peaked at $463K in Q1 2022. 370 funds tracked by Wall St. Rank hold SNV as of Q2 2023.

  • American Trust reported no remaining Synovus position as of Q2 2023 after selling out during the quarter.
  • American Trust sold 7,268 Synovus shares in Q2 2023, an estimated $224K.
  • American Trust first reported a position in Synovus in Q4 2021 and held it in 6 quarters.
  • American Trust's Synovus position peaked at $463K in Q1 2022.
  • 370 funds tracked by Wall St. Rank held Synovus as of Q2 2023.

Based on American Trust's 13F filing for Q2 2023, filed 14 Aug 2023.